Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen

Overview of attention for article published in Journal of Translational Medicine, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ENGINEERING STEM CELL T CELLS WITH MULTIPLE T CELL RECEPTORS

Application US-20230124097-A1

United States of America

NATURAL KILLER T (NKT) CELLS COMPRISING ENGINEERED T CELL RECEPTORS

Application WO-2018073596-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.